Evogene Ltd. EVGN

Full chart Compare
Set alert

Price alert · EVGN

All alert types
0.36 USD 0.00 (+1.25%)

At closeNov 4, 2026, 7:36 PM EST

0.35 -0.01 -1.63%

After hours · Nov 4, 7:36 PM ET

0.3503 Day range 0.3642
0.35 52-week range 1.28
YTD
-67.56%
1 year
-70.75%

Revenue & Expenses

Other Income → Expenses: $5.55MExpenses → Gross Loss: $241.00KExpenses → Selling, General & Admin: $5.76MExpenses → Research & Development: $7.99MExpenses → Other Operating Expenses: $37.00KExpenses → Income Tax: $1.00KNet Loss → Expenses: $8.48MRevenue → Cost of Revenue: $3.85MOther Income$5.55MNet Loss$8.48MCost of Revenue$4.09MExpenses$14.04MGross Loss$241.00KSelling, General & Admin$5.76MResearch & Development$7.99MOther Operating Expenses$37.00KIncome Tax$1.00KRevenue$3.85M

Latest period ending Dec 31, 2025 · select a line to chart its full history

EVGN annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
3.50M5.58M2.98M1.68M930.00K
-591.00K3.20M1.49M766.00K163.00K
-12.03M-18.80M-22.23M-26.94M-30.95M
-8.48M-16.48M-23.88M-26.64M-27.79M
-1.08-2.90-5.20-6.44-6.90
EVGN annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
12.99M15.31M20.77M28.98M32.33M
20.05M39.86M51.10M56.13M76.30M
8.07M25.03M22.42M21.34M12.88M
2.20M12.87M11.51M11.93M2.67M
-82.00K-1.45M12.05M27.93M53.65M
EVGN annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-13.50M-19.70M-21.58M-23.68M-24.72M
17.74M9.62M-4.54M13.27M-20.57M
-6.60M4.66M18.15M9.34M30.28M
-121.00K-616.00K-551.00K-1.17M-847.00K
-2.35M-5.47M-8.21M-3.35M-13.90M